Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Levitee Labs Inc C.LVT

Alternate Symbol(s):  LVTTF

Levitee Labs Inc. is a Canada-based integrative wellness company. The Company focuses on the centralization of integrative wellness assets. It is involved in transforming the traditional landscape of mental health, addiction, and pain management treatments through evidence-based complementary medicines and psychedelic therapies through its portfolio of wellness assets. The Company’s portfolio of assets includes Levitee Clinics, Levitee Pharmacies, Levitee Nutraceuticals and Sporeo. Levitee Clinics is a group of five operating addiction and pain treatment clinics in Alberta. Levitee Pharmacies includes three pharmacies operating in Alberta specialized in filling prescriptions for patients with substance use disorders, mental health conditions, and chronic pain. Levitee Nutraceuticals includes MONKE Nutra, Ojio, Earth Shift and Earth Circle Organics. Sporeo products are available through retail, wholesale, and ecommerce channels and defragments the mushroom cultivation ecosystem.


CSE:LVT - Post by User

Post by SkywalkerofLukeon Aug 05, 2021 4:41pm
216 Views
Post# 33660261

$LVT News

$LVT News

Coming off the news of their 4th acquisition in just two weeks yesterday, $LVT just announced the appointment of Dr. Fady Hannah-Shmouni, a leading expert in neuroendocrinology and genetics from the NIH, as Chief Medical and Scientific Officer and President of Levitee Clinics and Pharmacies. 


Dr. Hannah-Shmouni’s role will see him 


- Oversee $LVT ‘s medical affairs, research activities, and corporate medical strategy

- Work with relevant parties to provide oversight of $LVT ‘s clinical and scientific agenda

- Develop partnerships with a special focus on mental illness treatment, including substance use and pain disorders

- Etc. 


CEO of $LVT commented, “A practicing internist, neuroendocrinologist and geneticist coming from the world’s top scientific research institution, Dr. Hannah-Shmouni brings the complete package to our company.”


Great to see $LVT add someone with so much knowledge and experience to their team, definitely keeping my on these guys. 


https://www.leviteelabs.com/levitee-labs-appoints-nih-physician-scientist-dr-fady-hannah-shmouni-as-chief-medical-and-scientific-officer/

<< Previous
Bullboard Posts
Next >>